Data Collective Iv, L.p. - Net Worth and Insider Trading
Data Collective Iv, L.p. Net Worth
The estimated net worth of Data Collective Iv, L.p. is at least $9 Million dollars as of 2024-09-20. Data Collective Iv, L.p. is the 10% Owner of Embark Technology Inc and owns about 3,212,107 shares of Embark Technology Inc (EMBK) stock worth over $9 Million. Details can be seen in Data Collective Iv, L.p.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Data Collective Iv, L.p. has not made any transactions after 2022-08-30 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Data Collective Iv, L.p.
Data Collective Iv, L.p. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Data Collective Iv, L.p. owns 3 companies in total, including Recursion Pharmaceuticals Inc (RXRX) , Embark Technology Inc (EMBK) , and Northern Genesis Acquisition Corp II (NGAB.U) .
Click here to see the complete history of Data Collective Iv, L.p.’s form 4 insider trades.
Insider Ownership Summary of Data Collective Iv, L.p.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| RXRX | Recursion Pharmaceuticals Inc | 2021-04-15 | 10 percent owner |
| EMBK | Embark Technology Inc | 2022-08-30 | 10 percent owner |
| NGAB.U | Northern Genesis Acquisition Corp II | 2021-11-10 | 10 percent owner |
Data Collective Iv, L.p. Latest Holdings Summary
Data Collective Iv, L.p. currently owns a total of 1 stock. Data Collective Iv, L.p. owns 3,212,107 shares of Embark Technology Inc (EMBK) as of August 30, 2022, with a value of $9 Million.
Latest Holdings of Data Collective Iv, L.p.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| EMBK | Embark Technology Inc | 2022-08-30 | 3,212,107 | 2.88 | 9,250,868 |
Holding Weightings of Data Collective Iv, L.p.
Data Collective Iv, L.p. Form 4 Trading Tracker
According to the SEC Form 4 filings, Data Collective Iv, L.p. has made a total of 3 transactions in Embark Technology Inc (EMBK) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Embark Technology Inc is the acquisition of 10,000 shares on August 30, 2022, which cost Data Collective Iv, L.p. around $96,400.
Insider Trading History of Data Collective Iv, L.p.
- 1
Data Collective Iv, L.p. Trading Performance
GuruFocus tracks the stock performance after each of Data Collective Iv, L.p.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Data Collective Iv, L.p. is -61.76%. GuruFocus also compares Data Collective Iv, L.p.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Data Collective Iv, L.p. within 3 months outperforms 0 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Data Collective Iv, L.p.'s insider trading performs compared to the benchmark.
Performance of Data Collective Iv, L.p.
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -27.2 |  | | | | |
| Relative Return to S&P 500(%) | -17.31 | | | | | |
Data Collective Iv, L.p. Ownership Network
Data Collective Iv, L.p. Owned Company Details
What does Recursion Pharmaceuticals Inc do?
Who are the key executives at Recursion Pharmaceuticals Inc?
Data Collective Iv, L.p. is the 10 percent owner of Recursion Pharmaceuticals Inc. Other key executives at Recursion Pharmaceuticals Inc include Chief Financial Officer Michael Secora , director & 10 percent owner & Chief Executive Officer Christopher Gibson , and President and COO Tina Marriott Larson .
Recursion Pharmaceuticals Inc (RXRX) Insider Trades Summary
Over the past 18 months, Data Collective Iv, L.p. made no insider transaction in Recursion Pharmaceuticals Inc (RXRX). Other recent insider transactions involving Recursion Pharmaceuticals Inc (RXRX) include a net sale of 488,447 shares made by Blake Borgeson , a net sale of 1,280,678 shares made by Christopher Gibson , and a net sale of 82,000 shares made by Tina Marriott Larson .
In summary, during the past 3 months, insiders sold 378,129 shares of Recursion Pharmaceuticals Inc (RXRX) in total and bought 0 shares, with a net sale of 378,129 shares. During the past 18 months, 2,996,255 shares of Recursion Pharmaceuticals Inc (RXRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 2,996,255 shares.
Recursion Pharmaceuticals Inc (RXRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Recursion Pharmaceuticals Inc Insider Transactions
Data Collective Iv, L.p. Mailing Address
Above is the net worth, insider trading, and ownership report for Data Collective Iv, L.p.. You might contact Data Collective Iv, L.p. via mailing address: 317 University Ave, Suite 200, Palo Alto Ca 94301.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
